The skincare industry is increasingly looking beyond traditional anti-aging ingredients, with regenerative biotechnology emerging as one of the trends shaping the future of beauty. As consumers seek products that support healthier-looking skin and more comprehensive rejuvenation routines, exosomes are attracting growing attention.
Among the brands exploring this approach is Dr. Ivy Skincare, founded by Dr. Ivona Igerc, known as Dr. Ivy. With more than 25 years of experience in aesthetic medicine, Dr. Ivy has developed a skincare collection centered on regenerative approaches to skin rejuvenation.
One of the brand’s featured offerings is the Exosome Treatment Protocol, a three-step system designed to bring regenerative-inspired skincare into a daily beauty routine. The collection includes a Regenerative Exosome Cleanser, Exosome Serum and Exosome Face Cream, with each product serving a different purpose in the cleansing, treatment and moisturizing process.
According to the brand, the complete protocol features more than 43.5 million plant-derived exosomes across the three products. The system is designed to work in sequence, beginning with cleansing, followed by targeted serum application and finishing with a face cream to help seal in moisture.
Exosomes have become an increasingly discussed subject in beauty and biotechnology. These tiny extracellular vesicles play a role in cell-to-cell communication, carrying molecular signals between cells. In skincare, they are being explored for their potential applications in skin appearance, texture and rejuvenation.
However, the growing popularity of exosome-based products also makes consumer education important. Not all exosomes are the same, and the source, formulation and evidence supporting a particular product matter. Plant-derived exosomes, in particular, should not automatically be assumed to have the same biological effects as human-derived exosomes used in medical research.
The distinction between regenerative skincare marketing and established scientific evidence is an important part of the conversation. While research into exosomes and their potential applications continues, consumers should look carefully at product claims and understand what the available evidence actually supports.
Dr. Ivy brings an aesthetic medicine perspective to this evolving category. She can discuss why exosomes are gaining attention, how regenerative skincare differs from conventional anti-aging products, and what consumers should know when evaluating new biotechnology-inspired formulas.
As the beauty industry continues to embrace innovation, products such as the Exosome Treatment Protocol reflect a growing interest in combining skincare routines with emerging scientific approaches to maintaining healthy-looking skin.